Company research
Innovation Pharmaceuticals Inc.
CIK 1355250Updated Sep 27, 2026
SecurityIPIX · OTC · equity
Name history
Cellceutix CORP · through May 9, 2017EconoShare, Inc. · through May 15, 2008
IPIX price & chart
Loading TradingView…
OTC:IPIX on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2023 · USDSource
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 7,517,000Source | 10,379,000Source | 14,299,000Source | 9,248,000Source |
| Property, Plant and Equipment, NetUSD | — | — | — | 0Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 1,518,000Source | 3,807,000Source | 10,194,000Source | 6,018,000Source |
| Assets, CurrentUSD | 1,634,000Source | 3,952,000Source | 10,689,000Source | 6,110,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 116,000Source | 145,000Source | 495,000Source | 92,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 5,478,000Source | 5,649,000Source | 6,790,000Source | 7,786,000Source |
| Commitments and ContingenciesUSD | — | — | 0Source | — |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Additional Paid in CapitalUSD | 129,566,000Source | 129,090,000Source | 124,835,000Source | 102,819,000Source |
| Retained Earnings (Accumulated Deficit)USD | -125,325,000Source | -122,157,000Source | -115,116,000Source | -101,244,000Source |
| Stockholders' Equity Attributable to ParentUSD | 2,039,000Source | 4,730,000Source | 7,509,000Source | 1,462,000Source |
| Liabilities and EquityUSD | 7,517,000Source | 10,379,000Source | 14,299,000Source | 9,248,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 5,021,000Source | 4,808,000Source | 6,538,000Source | 7,369,000Source |
| Operating Lease, Liability, CurrentUSD | 55,000Source | 197,000Source | 165,000Source | 138,000Source |
| Accounts Payable, CurrentUSD | 2,985,000Source | 2,567,000Source | 2,563,000Source | 2,043,000Source |
| Operating Lease, Liability, NoncurrentUSD | 0Source | 55,000Source | 252,000Source | 417,000Source |
| Other Liabilities, NoncurrentUSD | 457,000Source | — | — | — |
| Additional Financial Items | ||||
| Accrued Liabilities, CurrentUSD | 73,000Source | 92,000Source | 348,000Source | 59,000Source |
| Dividends PayableUSD | — | — | — | 13,000Source |
cash flow · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | 7,041,000Source | -13,872,000Source | — |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 207,000Source | 583,000Source | 183,000Source | 427,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts PayableUSD | 418,000Source | 4,000Source | 520,000Source | -84,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -2,106,000Source | -6,280,000Source | -9,495,000Source | -4,156,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -60,000Source | -4,080,000Source | -72,000Source | -91,000Source |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | — | — | — | 100,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -123,000Source | 3,973,000Source | 13,743,000Source | 9,686,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 1,518,000Source | — | — | — |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 12,000Source | 59,000Source | 59,000Source | — |
| Income Taxes Paid, NetUSD | 0Source | 0Source | 0Source | — |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 207,000Source | 583,000Source | 8,000Source | 13,000Source |
| Amortization of Intangible AssetsUSD | 373,000Source | 382,000Source | 378,000Source | 372,000Source |
| DepreciationUSD | — | — | — | 1,000Source |
| Derivative, Gain (Loss) on Derivative, NetUSD | — | — | — | 102,000Source |
| Dividends PayableUSD | — | — | — | 13,000Source |
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber PropertyUSD | — | — | — | 0Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | 0Source | — |
| Gain (Loss) on Extinguishment of DebtUSD | 0Source | 172,000Source | — | — |
| General and Administrative ExpenseUSD | 750,000Source | 1,223,000Source | 963,000Source | 1,429,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | -2,100,000Source | -6,300,000Source | — | -4,635,000Source |
| Income (Loss) from Equity Method InvestmentsUSD | -172,000Source | -22,000Source | — | — |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source |
| Insured Event, Gain (Loss)USD | 481,000Source | 63,000Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | -3,168,000Source | -7,041,000Source | -13,872,000Source | -6,648,000Source |
| Operating ExpensesUSD | 2,939,000Source | 6,917,000Source | 9,015,000Source | 5,058,000Source |
| Operating Lease, Impairment LossUSD | 643,000Source | 643,000Source | 0Source | 643,000Source |
| Other Nonoperating Income (Expense)USD | -57,000Source | — | — | — |
| Other Operating Income (Expense), NetUSD | -172,000Source | — | — | — |
| Payments to Acquire InvestmentsUSD | 0Source | — | — | — |
| Proceeds from Stock Options ExercisedUSD | 0Source | 23,000Source | — | — |
income statement · annual statements
| Line item | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Total RevenueUSD | 0Source | 18,000Source | 0Source | 423,000Source |
| Operating Income (Loss)USD | -3,111,000Source | -6,921,000Source | -9,015,000Source | — |
| Other Nonoperating Income (Expense)USD | -57,000Source | — | — | — |
| Income Tax Expense (Benefit)USD | 0Source | 0Source | 0Source | 0Source |
| Net Income (Loss) Attributable to ParentUSD | -3,168,000Source | -7,041,000Source | -13,872,000Source | -6,648,000Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 373,000Source | 382,000Source | 378,000Source | 372,000Source |
| General and Administrative ExpenseUSD | 750,000Source | 1,223,000Source | 963,000Source | 1,429,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | -2,100,000Source | -6,300,000Source | — | -4,635,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -3,168,000Source | -7,041,000Source | -13,872,000Source | -6,648,000Source |
| Income (Loss) from Continuing Operations, Per Basic ShareUSD per share | — | — | -0.04Source | — |
| Income (Loss) from Equity Method InvestmentsUSD | -172,000Source | -22,000Source | — | — |
| Interest ExpenseUSD | — | — | — | 52,000Source |
| Interest Expense, DebtUSD | 28,000Source | 68,000Source | 155,000Source | -208,000Source |
| Labor and Related ExpenseUSD | 482,000Source | 428,000Source | 499,000Source | 480,000Source |
| Operating ExpensesUSD | 2,939,000Source | 6,917,000Source | 9,015,000Source | 5,058,000Source |
| Other ExpensesUSD | — | 120,000Source | 4,857,000Source | 2,013,000Source |
| Other IncomeUSD | 0Source | 172,000Source | — | — |
| Other Operating IncomeUSD | — | 22,000Source | — | — |
| Other Operating Income (Expense), NetUSD | -172,000Source | — | — | — |
| Research and Development ExpenseUSD | 1,462,000Source | 4,814,000Source | 7,016,000Source | 2,792,000Source |